相关实验视频

Updated: Sep 13, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.5K

工程TAG-72和CD30CAR-T细胞用于T细胞恶性瘤

Van To1,2, Vera J Evtimov1,2, Runzhe Shu1,2

  • 1Cartherics Pty Ltd, Notting Hill, Victoria, Australia.

Immunological investigations
|August 1, 2025
PubMed
概括

化学抗原受体 (CAR) -T细胞疗法在T细胞恶性瘤中显示出前景. 用CAR-T细胞向TAG-72和CD30抗原证明了有效性,特别是在攻击性癌症的联合治疗中.

关键词:
在CART-T中,我们可以使用CAR-T.CD3030 是一个CD3030 是一个CD30.在T细胞淋巴瘤.在TAG-72中.聚合的CARCAR是一个聚合的CAR.

更多相关视频

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level08:09

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level

Published on: March 14, 2025

1.1K
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.5K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662